| 16th September 2015
We are pleased to announce that Blue Latitude have been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region. Following this renewed three year contract, we will continue our successful partnership with Janssen, offering our full breadth of services across a wide range of therapy areas. Talking about the partnership, leadership from both companies had the following to say;
The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., psoriasis), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes). Driven by a commitment to patients, Janssen develops sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. For their latest news, follow Janssen on Twitter: @JanssenEMEA.
| 30th October 2017
Simon Young Director and Head of Commercial at Blue Latitude Health gives an engaging speech on the customer-centred future of medical information at Novartis ICE Innovation Day
| 2nd October 2017
At Blue Latitude Health, we pride ourselves on our unique, inclusive culture. Here, Senior Talent Manager Deborah Braud explains her role in recruiting the top people from across industry, and why our ‘family-like’ values are crucial to our success.